Back
Matthews Emerging Markets Ex Chn Act ETF Vs. Astrana Health Industry Stock Comparison
Buy
57
MEMX
Matthews Emerging Markets Ex Chn Act ETF
Last Price:
29.62
Seasonality Move:
8.21%
Sell
18
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
Buy
57
Matthews Emerging Markets Ex Chn Act ETF (MEMX)
is a Buy
Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.93. The Score for MEMX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $46.8100. The Score for ASTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MEMX Stock Price Chart
What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?
-
The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing selling pressure, which indicates risk of future bearish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $46.8100
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight selling pressure.
MEMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 38.15 | Sell |
| Chaikin Money Flow: | -1315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.24 - 30.74) | Sell |
| Bollinger Bands (100): | (29.81 - 30.97) | Sell |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.22 | Sell |
| Relative Strength Index (14 RSI): | 31.55 | Sell |
| Chaikin Money Flow: | -120939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.9492 - 60.3292) | Sell |
| Bollinger Bands (100): | (44.5893 - 56.9893) | Sell |
MEMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.2 | Sell |
| 20-day SMA: | 30.46 | Sell |
| 50-day SMA: | 30.55 | Sell |
| 200-day SMA: | 29.59 | Buy |
| 8-day EMA: | 30.24 | Sell |
| 20-day EMA: | 30.39 | Sell |
| 50-day EMA: | 30.45 | Sell |
| 200-day EMA: | 29.51 | Buy |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.86 | Sell |
| 20-day SMA: | 56.32 | Sell |
| 50-day SMA: | 55.22 | Sell |
| 200-day SMA: | 45.24 | Buy |
| 8-day EMA: | 52.97 | Sell |
| 20-day EMA: | 55 | Sell |
| 50-day EMA: | 54.44 | Sell |
| 200-day EMA: | 46.93 | Sell |
Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
Matthews Emerging Markets Ex Chn Act ETF Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||